The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3651037)

Published in World Allergy Organ J on June 01, 2008

Authors

Werner J Pichler1

Author Affiliations

1: From the Division of Allergology, Clinic for Rheumatology and Clinical Immunology/Allergology, University of Berne, Berne, Switzerland.

Articles cited by this

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol (2002) 13.10

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48

Medical genetics: a marker for Stevens-Johnson syndrome. Nature (2004) 5.43

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A (2005) 3.82

Hepatic T cells and liver tolerance. Nat Rev Immunol (2003) 3.51

Delayed drug hypersensitivity reactions. Ann Intern Med (2003) 3.06

Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet (2000) 2.43

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci U S A (2004) 2.15

A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med (2004) 1.91

A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol (2001) 1.90

A marker for Stevens-Johnson syndrome ...: ethnicity matters. Pharmacogenomics J (2006) 1.73

p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J Invest Dermatol (2003) 1.69

The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest (2004) 1.53

HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J Clin Invest (1998) 1.36

Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol (2003) 1.35

Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest (1997) 1.32

Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today (1998) 1.30

Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol (2000) 1.20

HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol (2007) 1.20

Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy (2007) 1.15

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol (2000) 1.13

Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy (2000) 1.11

A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med (2003) 1.10

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol (2002) 1.09

Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol (2003) 1.08

T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy (2006) 1.07

Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol (2003) 1.05

Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther (1992) 1.05

Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf (2000) 1.03

Detection of specific IgE to quinolones. J Allergy Clin Immunol (2004) 1.03

Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones. Int Immunol (1998) 0.98

Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol (1997) 0.97

Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol (2007) 0.96

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol (2001) 0.94

Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J Allergy Clin Immunol (2004) 0.91

Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. Int Immunol (2001) 0.91

HIV and drug allergy. Curr Opin Allergy Clin Immunol (2001) 0.89

Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol (2002) 0.87

A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Toxicology (2004) 0.86

Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br J Pharmacol (2001) 0.86

T cell involvement in cutaneous drug eruptions. Clin Exp Allergy (2001) 0.85

Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides. Clin Exp Allergy (2002) 0.84

Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Mol Pharmacol (2006) 0.83

Direct T-cell stimulations by drugs--bypassing the innate immune system. Toxicology (2005) 0.82

Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells. J Invest Dermatol (1999) 0.81

Recognition of local anesthetics by alphabeta+ T cells. J Invest Dermatol (1999) 0.81

Lessons from drug allergy: against dogmata. Curr Allergy Asthma Rep (2003) 0.77